Linked Data API

Show Search Form

Search Results

446823
star this property registered interest false more like this
star this property date less than 2016-01-21more like thismore than 2016-01-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
unstar this property answering dept sort name Health more like this
star this property hansard heading Antimicrobials: Drug Resistance more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what estimate he has made of the (a) cost to the economy and (b) number of deaths attributable to antimicrobial resistance in the last 12 months for which figures are available; whether he has made such estimates for future years; and if he will make a statement. more like this
star this property tabling member constituency Stafford remove filter
star this property tabling member printed
Jeremy Lefroy more like this
unstar this property uin 23658 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer remove filter
star this property answer text <p>A broad estimate of the cost of antimicrobial resistance to the National Health Service is £180 million per annum.</p><br /><p>Antimicrobial resistance is a global problem. In the longer term, a forecast of the global economic costs and deaths attributable to antimicrobial resistance is available from the independent review on antimicrobial resistance led by Lord O'Neill of Gatley. His review estimates that drug-resistant infections could kill an extra 10 million people globally every year by 2050, and have a cumulative cost to the world of around $100 trillion in lost output.</p><p><strong></strong></p><p>The United Kingdom is taking the lead in addressing antimicrobial resistance globally, investing £265 million in the Fleming Fund to strengthen surveillance of drug resistance and laboratory capacity in developing countries.</p> more like this
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property question first answered
less than 2016-01-28T17:12:03.82Zmore like thismore than 2016-01-28T17:12:03.82Z
unstar this property answering member
3918
star this property label Biography information for Jane Ellison more like this
star this property tabling member
4109
unstar this property label Biography information for Jeremy Lefroy more like this